216 related articles for article (PubMed ID: 29371698)
1. Rab25 augments cancer cell invasiveness through a β1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin.
Jeong BY; Cho KH; Jeong KJ; Park YY; Kim JM; Rha SY; Park CG; Mills GB; Cheong JH; Lee HY
Exp Mol Med; 2018 Jan; 50(1):e435. PubMed ID: 29371698
[TBL] [Abstract][Full Text] [Related]
2. RCP induces Slug expression and cancer cell invasion by stabilizing β1 integrin.
Hwang MH; Cho KH; Jeong KJ; Park YY; Kim JM; Yu SL; Park CG; Mills GB; Lee HY
Oncogene; 2017 Feb; 36(8):1102-1111. PubMed ID: 27524413
[TBL] [Abstract][Full Text] [Related]
3. Rab25 promotes erlotinib resistance by activating the β1 integrin/AKT/β-catenin pathway in NSCLC.
Wang J; Zhou P; Wang X; Yu Y; Zhu G; Zheng L; Xu Z; Li F; You Q; Yang Q; Zhuo W; Sun J; Chen Z
Cell Prolif; 2019 May; 52(3):e12592. PubMed ID: 30848009
[TBL] [Abstract][Full Text] [Related]
4. Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT.
Mitra S; Federico L; Zhao W; Dennison J; Sarkar TR; Zhang F; Takiar V; Cheng KW; Mani S; Lee JS; Mills GB
Oncotarget; 2016 Jun; 7(26):40252-40265. PubMed ID: 27259233
[TBL] [Abstract][Full Text] [Related]
5. Rab25 suppresses colon cancer cell invasion through upregulating claudin‑7 expression.
Cho SJ; Jeong BY; Yoon SH; Park CG; Lee HY
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38131227
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3β/Snail signaling.
Zhang J; Wei J; Lu J; Tong Z; Liao B; Yu B; Zheng F; Huang X; Chen Z; Fang Y; Li B; Chen W; Xie D; Luo J
Carcinogenesis; 2013 Oct; 34(10):2401-8. PubMed ID: 23722651
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer.
Gomez-Roman N; Sahasrabudhe NM; McGregor F; Chalmers AJ; Cassidy J; Plumb J
Oncotarget; 2016 Apr; 7(16):22650-64. PubMed ID: 26967059
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor function of Rab25 in triple-negative breast cancer.
Cheng JM; Volk L; Janaki DK; Vyakaranam S; Ran S; Rao KA
Int J Cancer; 2010 Jun; 126(12):2799-812. PubMed ID: 19795443
[TBL] [Abstract][Full Text] [Related]
9. Let-7d and miR-185 Impede Epithelial-Mesenchymal Transition by Downregulating Rab25 in Breast Cancer.
Shahabi A; Naghili B; Ansarin K; Montazeri M; Dadashpour M; Zarghami N
Asian Pac J Cancer Prev; 2021 Jan; 22(1):305-313. PubMed ID: 33507713
[TBL] [Abstract][Full Text] [Related]
10. Rab25 regulates integrin expression in polarized colonic epithelial cells.
Krishnan M; Lapierre LA; Knowles BC; Goldenring JR
Mol Biol Cell; 2013 Mar; 24(6):818-31. PubMed ID: 23345591
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of RAB25 expression by RNAi inhibits growth of human epithelial ovarian cancer cells in vitro and in vivo.
Fan Y; Xin XY; Chen BL; Ma X
Pathology; 2006 Dec; 38(6):561-7. PubMed ID: 17393986
[TBL] [Abstract][Full Text] [Related]
12. MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25.
Yin C; Mou Q; Pan X; Zhang G; Li H; Sun Y
Thorac Cancer; 2018 Apr; 9(4):472-479. PubMed ID: 29524309
[TBL] [Abstract][Full Text] [Related]
13. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers.
Cheng KW; Lahad JP; Kuo WL; Lapuk A; Yamada K; Auersperg N; Liu J; Smith-McCune K; Lu KH; Fishman D; Gray JW; Mills GB
Nat Med; 2004 Nov; 10(11):1251-6. PubMed ID: 15502842
[TBL] [Abstract][Full Text] [Related]
14. β1 Integrin is essential for fascin-mediated breast cancer stem cell function and disease progression.
Barnawi R; Al-Khaldi S; Colak D; Tulbah A; Al-Tweigeri T; Fallatah M; Monies D; Ghebeh H; Al-Alwan M
Int J Cancer; 2019 Aug; 145(3):830-841. PubMed ID: 30719702
[TBL] [Abstract][Full Text] [Related]
15. Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition.
Yagi H; Yotsumoto F; Miyamoto S
Mol Cancer Ther; 2008 Oct; 7(10):3441-51. PubMed ID: 18852147
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
[TBL] [Abstract][Full Text] [Related]
17. Loss of RAB25 Cooperates with Oncogenes in the Transformation of Human Mammary Epithelial Cells (HMECs) to Give Rise to Claudin-Low Tumors.
Joshi P; Ayyagari V; Kandel S; Modur V; Iqbal MF; Robinson K; Gao J; Rao K
Biomed Res Int; 2024; 2024():8544837. PubMed ID: 38803515
[TBL] [Abstract][Full Text] [Related]
18. Loss of Rab25 promotes the development of skin squamous cell carcinoma through the dysregulation of integrin trafficking.
Jeong H; Lim KM; Kim KH; Cho Y; Lee B; Knowles BC; Roland JT; Zwerner JP; Goldenring JR; Nam KT
J Pathol; 2019 Oct; 249(2):227-240. PubMed ID: 31144312
[TBL] [Abstract][Full Text] [Related]
19. Fascin is involved in cancer cell invasion and is regulated by stromal factors.
Zhang X; Cho IH; Park JH; Lee MK; Hwang YS
Oncol Rep; 2019 Jan; 41(1):465-474. PubMed ID: 30542700
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of Rab25 in breast cancer correlates with lymphatic metastasis.
Yin YX; Shen F; Pei H; Ding Y; Zhao H; Zhao M; Chen Q
Tumour Biol; 2012 Oct; 33(5):1581-7. PubMed ID: 22644676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
